Flurizan – Anti-Amyloid Drug for Treatment of Alzheimer’s Disease
Key Data:
Drug (Brand/Generic)
Flurizan (tarenflurbil)
Company/Licensee
Myriad Pharmaceuticals/Lundbeck
Therapy Class
Anti-amyloid agents
Product Description
Selective amyloid lowering agent
Current Indication
Alzheimer’s disease
Market Sector
CNS
Development Status
Discontinued
